Publication: The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use
Issued Date
2020-07-01
Resource Type
ISSN
18729649
15681637
15681637
Other identifier(s)
2-s2.0-85083638097
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Ageing Research Reviews. Vol.60, (2020)
Suggested Citation
Mayuri Shukla, Bruno Vincent The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use. Ageing Research Reviews. Vol.60, (2020). doi:10.1016/j.arr.2020.101062 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54457
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use
Author(s)
Other Contributor(s)
Abstract
© 2020 Elsevier B.V. Although it has been initially synthesized for therapeutic purposes and currently FDA-approved and prescribed for obesity, attention-deficit/hyperactivity disorder, narcolepsy and depression, methamphetamine became a recreational drug that is nowadays massively manufactured illegally. Because it is a powerful and extremely addictive psychotropic agent, its abuse has turned out to become a major health problem worldwide. Importantly, the numerous effects triggered by this drug induce neurotoxicity in the brain ultimately leading to serious neurological impairments, tissue damage and neuropsychological disturbances that are reminiscent to most of the symptoms observed in Alzheimer's disease and other pathological manifestations in aging brain. In this context, there is a growing number of compelling evidence linking methamphetamine abuse with a higher probability of developing premature Alzheimer's disease and consequent neurodegeneration. This review proposes to establish a broad assessment of the effects that this drug can generate at the cellular and molecular levels in connection with the development of the age-related Alzheimer's disease. Altogether, the objective is to warn against the long-term effects that methamphetamine abuse may convey on young consumers and the increased risk of developing this devastating brain disorder at later stages of their lives, but also to discuss a more recently emerging concept suggesting a possible use of methamphetamine for treating this pathology under proper and strictly controlled conditions.